FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#5 | ||
|
|||
Member
|
To keep the PML discussion in perspective:
European Doctors are not exactly shying away from using Tysabri in immunnosuppressed patients (which is identified as a potential risk factor for higher occurrence of PML) Natalizumab treatment after autologous haematopoietic stem cell transplantation in patients with aggressive multiple sclerosis http://registration.akm.ch/einsicht....NMASKEN_ID=900 Any wonder the PML case count is 2 in the US and 7 ex-US (Europe) |
||
![]() |
![]() |
|
|
![]() |
||||
Thread | Forum | |||
New Tysabri PML case - ex-US and 35 months of use | Multiple Sclerosis | |||
Tysabri - 9th case of PML | Multiple Sclerosis | |||
Biogen Reveals Another Tysabri PML Case | Multiple Sclerosis | |||
Another Tysabri/PML case; This time in the US | Multiple Sclerosis |